23,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Conventional drug therapies suffer from several limitations most prominently the pharmacokinetic alterations in biological system which results in decreased bioavailability at the desired site of action. Furthermore, the undesired distribution, biotransformation and elimination lead to cause serious toxicities and sub-maximal therapeutic efficacy. The concept of Targeted Drug Delivery Systems (TDDS) thus emerged to limit these consequences and exaggerate the therapeutic value of the medicine.

Produktbeschreibung
Conventional drug therapies suffer from several limitations most prominently the pharmacokinetic alterations in biological system which results in decreased bioavailability at the desired site of action. Furthermore, the undesired distribution, biotransformation and elimination lead to cause serious toxicities and sub-maximal therapeutic efficacy. The concept of Targeted Drug Delivery Systems (TDDS) thus emerged to limit these consequences and exaggerate the therapeutic value of the medicine.
Autorenporträt
Dr. Dipanjana Ghosh hat 2013 an der National University of Singapore promoviert. Sie arbeitete als Post-Doc-Forschungsstipendiatin an der NUS und als außerordentliche Professorin an der School of Pharmacy & Research, People's University, Bhopal. Sie verfügt über ein breit gefächertes Fachwissen auf dem Gebiet der Pharmazeutik und der Biowissenschaften.